{Reference Type}: Journal Article
{Title}: Prognostic value of PAX8 in small cell lung cancer.
{Author}: Tao F;Zhu H;Xu J;Guo Y;Wang X;Shao L;Pan D;Li G;Fang R;
{Journal}: Heliyon
{Volume}: 10
{Issue}: 7
{Year}: 2024 Apr 15
{Factor}: 3.776
{DOI}: 10.1016/j.heliyon.2024.e28251
{Abstract}: <B>UNASSIGNED: </B>Small cell lung cancer (SCLC) shows poor prognosis since it metastasizes widely at early stage. Paired box gene (PAX) 8 is a transcriptional factor of PAX family, of which the expression in lung cancer is a controversial issue, and its prognostic value of PAX8 in SCLC is still unclear.<BR><B>UNASSIGNED: </B>Overall, 184 subjects who were pathologically diagnosed with SCLC were enrolled in the study. Immunohistochemical analysis of PAX8 and Ki-67 were performed. The correlations between PAX8 expression and clinical features or Ki-67 index were further analyzed. Subsequently, an analysis of the association between PAX8, stage, Ki-67 status, and overall survival (OS) were performed in 169 subjects with follow-up information.<BR><B>UNASSIGNED: </B>PAX8 was positive in 53.8% (99/184) SCLC specimens. The positive rate is significantly higher in extensive-stage specimens (61.0%) than in limited-stage specimens (45.24%). PAX8 expression is positively correlated with Ki-67 index (P = 0.001) while negatively correlated with OS (HR = 3.725, 95% CI 1.943-7.139, P＜0.001). In combination groups, the PAX8 negative and limited stage group had the most promising OS.<BR><B>UNASSIGNED: </B>PAX8 expression rate in SCLC specimens is not low. It has prognostic value in small cell lung cancer.